Evaluierung der adjuvanten Therapie beim Dickdarmkrebs im Stadium II nach ctDNA-Bestimmung (CIRCULATE) AIO-KRK-0217 Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE) AIO-KRK-0217 Investigator-initiated, multicentre, prospective, randomised, controlled study outcome
AIO-KRK-0418: Post-resection therapy with mFOLFOXIRI in patients with colorectal cancer (PORT). Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer